Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 25, 2022
Patent Application Number
16830831
Date Filed
March 26, 2020
Patent Citations
Patent Citations Received
...
Patent Primary Examiner
The present disclosure provides methods of modulating an immune response in an individual. The present disclosure provides methods of treatment. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) and an immune checkpoint inhibitor to an individual. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) to an individual who is undergoing treatment with immune checkpoint inhibitor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
